Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02508467
Title A Phase 1 Study of BLU-554 in Patients With Hepatocellular Carcinoma and Cholangiocarcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Blueprint Medicines Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CHE


No variant requirements are available.